课题基金 / 基金详情

TOXICANT-INDUCED DEREGULATION OF C-HA-RAS EXPRESSION

TOXICANT-INDUCED DEREGULATION OF C-HA-RAS EXPRESSION
毒物引起的 C-HA-RAS 表达失调
批准号:
2414959
负责人:
CHRISTOPHER M BRAL
金额:
$0.82万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
未结题
起止时间:
1997-05-01 至

项目摘要

项目成果

CHRISTOPHER M BRAL的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Atherosclerosis is one of the leading causes of death in developed industrialized nations. Several experimental and epidemiological studies have established a link between toxic environmental or occupational chemicals and atherogenesis. Benzo(a)pyrene (BaP) has been demonstrated to induce smooth muscle cell (SMC) proliferation both in vivo and in vitro, a process which represents a hallmark of atherogenesis. BaP also increases the expression of c-Ha-ras, a protooncogene found in approximately 20% of human tumors, in cultured vascular SMCs. The proposed studies are designed to investigate the molecular mechanisms resulting in altered ras expression, which may contribute to establishment of a proliferative phenotype in BaP-treated SMCs. The DNA sequence elements mediating the BaP response will be identified using a complementary approach of mutational analysis and transient transfection assays, coupled to in vitro DNA- binding assays. Structure-activity relationships for c-Ha-ras induction will be defined through use of representative chemicals which are major BnP metabolites, induce oxidative stress, and/or are ligands of the Ah receptor. Molecular targets of BaP-inducible DNA-binding proteins will be identified using in vitro DNA-binding assays employing immunodepleted nuclear extracts and recombinant basal transcription factors. Elucidation of the mechanisms by which BaP modulates c-Ha-ras transcription may have significant implications for proliferative adaptations of treated SMCs, as well as for toxicant-induced atherosclerosis in humans.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
TOXICANT-INDUCED DEREGULATION OF C-HA-RAS EXPRESSION
  • 批准号:
    2154576
  • 项目类别:
  • 资助金额:
    $2.86万
  • 财政年份:
    1996
  • 负责人:
    CHRISTOPHER M BRAL
  • 依托单位:
海外基金